Last Updated: May 13, 2026

Suppliers and packagers for PROCHLORPERAZINE MALEATE


✉ Email this page to a colleague

« Back to Dashboard


PROCHLORPERAZINE MALEATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Ajanta Pharma Ltd PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 218515 ANDA Ajanta Pharma USA Inc. 27241-286-01 100 TABLET in 1 BOTTLE (27241-286-01) 2024-05-09
Ajanta Pharma Ltd PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 218515 ANDA Ajanta Pharma USA Inc. 27241-287-01 100 TABLET in 1 BOTTLE (27241-287-01) 2024-05-09
Ajanta Pharma Ltd PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 218515 ANDA REMEDYREPACK INC. 70518-4319-0 10 TABLET in 1 BOTTLE, PLASTIC (70518-4319-0) 2025-03-25
Amneal PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 216598 ANDA Amneal Pharmaceuticals NY LLC 60219-2038-1 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60219-2038-1) 2023-04-21
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for PROCHLORPERAZINE MALEATE

Last updated: April 24, 2026

Who Supplies Prochlorperazine Maleate?

No complete, reliable supplier dataset can be produced from the information available in this chat.

What supplier coverage exists for Prochlorperazine Maleate?

  • No validated manufacturer-to-market (API vs. finished dose), grade (USP/EP/BP), strength, dosage-form, or geography mapping is provided here.
  • No trade-name mapping (for example, tablet vs. injection vs. API) is provided here.
  • No source list or procurement-ready catalog data is provided here.

How to classify suppliers for this molecule (so procurement is actionable)

Prochlorperazine maleate supply typically splits into two procurement streams: 1) API manufacturers (prochlorperazine maleate or equivalent salt form) 2) Finished-dose manufacturers (tablets, suppositories, injectable products)

Without verified product-grade and dosage-form scope, any supplier list would not be procurement-accurate.

What is required to build a valid supplier list

A supplier list must tie each supplier to:

  • Supply type: API or finished dose
  • Regulatory grade: USP, EP, BP, or equivalent
  • Salt confirmation: prochlorperazine maleate (not free base)
  • Dosage form (if finished dose): tablet, injection, suppository (etc.)
  • Geography and status: market authorization holder vs. manufacturing site vs. exporter/distributor

None of these fields are present in the provided inputs.


Key Takeaways

  • A complete, accurate supplier list for prochlorperazine maleate cannot be generated from the information available here.
  • Supplier identification must be mapped to API vs. finished dose and grade/dosage-form, otherwise the list is not procurement-usable.

FAQs

1) Is prochlorperazine maleate supplied as API or only as finished dose?
It is supplied both ways, depending on the supplier and customer procurement need.

2) How do buyers verify the correct substance form?
Buyers verify the exact salt form as prochlorperazine maleate and confirm grade standards (USP/EP/BP).

3) Do API suppliers and finished-dose manufacturers overlap?
They can, but procurement should treat them as distinct qualification paths.

4) What regulatory documents matter for supplier selection?
Buyers typically require confirmations tied to pharmacopeial grade and quality system compliance.

5) Can a generic supplier name list be used for procurement?
Only if it includes dosage form or API grade details and links to manufacturing and quality documentation.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.